CompaniesZionexa

Zionexa

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (3)
View all

Total Trials

3

As Lead Sponsor

1

As Collaborator

2

Total Enrollment

503

By Phase

PHASE3: 2

By Status

RECRUITING: 2TERMINATED: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
NCT04265209
NCT06195709
Hover over trial bars to see details

Recent Trials

NCT06195709Collaborator
ECLECTIC: EstroTEP and Circulating Biomarkers for ER-positive HER2-negative Metastatic Breast Cancer Patients
PHASE3Recruiting
300 participants
Started: May 27, 2024 · Completed: Sep 27, 2029
NCT05068726Collaborator
Clinical Utility of FES F18 PET/CT in Metastatic Breast Cancer Patients
N/ATerminated
51 participants
Started: Jan 5, 2023 · Completed: Jun 1, 2024
NCT04265209Lead Sponsor
[18F] LBT-999 PET Compared to [123I]-FP/CIT SPECT to Distinguish Between Parkinson's Diseases and Essential Tremor
PHASE3Recruiting
152 participants
Started: Dec 1, 2021 · Completed: Dec 31, 2024
Related Companies
Gehealthcare
acquired